Julie Mankikian

Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial

Julie Mankikian, Agnès Caille, Martine Reynaud‐Gaubert et al. · European Respiratory Journal · 2023 · 111 citations · Full text

Neurological manifestations of COVID-19 in adults and children

Sung‐Min Cho, Nicole White, Lavienraj Premraj et al. · Brain · 2022 · 83 citations · Full text

Virus Epidemiology, Covid-19 Epidemiology, Covid-19 +21

Theratyping cystic fibrosis patients to guide elexacaftor/tezacaftor/ivacaftor out-of-label prescription

Elise Dréano, Pierre‐Régis Burgel, Aurélie Hatton et al. · European Respiratory Journal · 2023 · 83 citations

Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19

Christiana Kartsonaki, J. Kenneth Baillie, Noelia García Barrio et al. · International Journal of Epidemiology · 2023 · 68 citations · Full text

Effect of one-year lumacaftor–ivacaftor treatment on glucose tolerance abnormalities in cystic fibrosis patients

Bastien Misgault, Eva Chatron, Quitterie Reynaud et al. · Journal of Cystic Fibrosis · 2020 · 66 citations · Full text

Glucose Tolerance Abnormalities, One-year Lumacaftor–ivacaftor Treatment, Cystic Fibrosis Patients +3